Reactogenicity of the simultaneous administration of influenza and pneumococcal vaccines in adults over 55 years of age;Reactogenicidad de la administración simultánea de las vacunas contra influenza y neumococo en adultos mayores de 55 años de edad

Revista de Investigacion Clinica

Volumn 56, Issue 1, 2004, Pages 27-31

  Ayala Montiel, Octavio ^a   Mascareñas de los Santos, César ^b   García Hernández, Delfino ^c   Rendón Muñiz, Jorge ^a   García Olvera, Laura ^c  

^a Hospital Central Sur   (Mexico)

^b Aventis Pasteur   (Mexico)

^c PEMEX   (Mexico)

Author keywords

Fluzone ; Imovax Neumo; Influenza; Pneumococcus; Safety; Simultaneous administration

Indexed keywords

DIPLOID CELL VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; INFLUENZA; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES;

EID: 2342424986     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults ≥ 65 years (United States 1997). Morbid Mortal Wkly Rep 1998; 47: 797-802.
2. Nicholson KG, Wiselka MJ, May A. Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985-86 immunization program in Trent, UK. Vaccine 1987; 5: 302-6.
3. Principales Causas de Mortalidad General. Estados Unidos Mexicanos, 1999. INEGI, SSA/DGEI, 2000.
4. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid Mortal Wkly Rep 1997; 46(No. RR-8).
5. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993; 328: 761-5.
6. Christenson B, Lundbergh P, Hdlund J, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001; 357: 1008-11.
7. Baker WH, Mullooly JP. Influenza vaccination of elderly persons: reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980; 244: 2547-9.
8. Nordin J, Mullooly J, Poblete S, et al. Influenza Vaccine Effectiveness in Preventing Hospitalizations and Deaths in Persons 65 years or Older in Minnesota, New York, and Oregon: Data from 3 Health Plans. J Infect Dis 2001; 184: 665-70.
9. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-60.
10. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-31.
11. Nichol K, Baken L, Wuorenma J, et al. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159: 2437-42.
12. Nichol K, Goodman M. The Health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmacoeconomics 1999; 16(S1): 63-71.
13. Nichol K. Complications of influenza and benefits of vaccination. Vaccine 1999; 17: S47-52.
14. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza. Morbid Mortal Wkly Rep 2000; 49: (RR03).
15. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Use of standing orders programs to increase adult vaccination rates. Morbid Mortal Wkly Rep 2000; 49: (RR01).
16. Nichol K. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17: S91-93.
17. Datos Internos Petróleos Mexicanos.
18. Información obtenida del sitio web de la Organización Mundial de la Salud: http://oms2.b3e.jussieu.fr/flunet/
19. Cartson AJ, Davidson WL, McLean AA, et al. Pneumococcal vaccine: dose, revaccination and co administration with influenza vaccine. Proc Soc Exp Biol Med 1979; 161: 558-63.
20. DeStefano F, Goodman RA, Noble GR, et al. Simultaneous administration of influenza and pneumococcal vaccines. JAMA 1982; 247: 2551-4.
21. Margolis KL, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly. JAMA 1990; 264: 1139-41.
22. Govaert TM, Dinant GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people: randomized double-blind placebo-controlled trial. BMJ 1993; 307: 988-90.
23. Fumara NJ, Waterman GE. Statewide geriatric immunization program with polyvalent pneumococcal vaccine. Curr Ther Res 1979; 25: 185-92.
24. Ponka A, Leinonen M. Adverse reactions to polyvalent pneumococcal vaccine. Scand J Infect Dis 1982; 14: 67-71.
25. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991; 91: 393-400.
26. Nichol KL, Lofgren RP, Gapinski J. Influenza vaccination: knowledge, attitudes, and behavior among high-risk outpatients. Arch Intern Med 1992; 152: 106-10.
27. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993; 137: 977-88.
28. Glezen PW. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4:25-44.
29. Mactartane JT, Colville A, Guion A, et al. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993; 341: 511-14.
30. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889-93.
31. Govaert TME, Dinart GJ, Aretz K, et al. Adverse reactions to influenza vaccine in elderly people:randomized double-blind placebo-controlled trial. BMJ 1993; 307: 988-90.
32. Palache AM, Beyer WEP, Sprenger MJW, et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-center, dose response study in elderly, nursing home residents and young volunteers. Vaccine 1993; 11: 3-9.
33. Roghmann KJ, Tabloski PA, Bentley DW, et al. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol 1987; 42: 265-70.